Anzeige
Mehr »
Login
Donnerstag, 24.04.2025 Börsentäglich über 12.000 News von 692 internationalen Medien
Jetzt knallt's an der Börse! Diese Aktie hat das Zeug zum Überflieger!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PZ3E | ISIN: US18507C1036 | Ticker-Symbol:
NASDAQ
23.04.25
21:59 Uhr
13,320 US-Dollar
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
CLEARPOINT NEURO INC Chart 1 Jahr
5-Tage-Chart
CLEARPOINT NEURO INC 5-Tage-Chart

Aktuelle News zur CLEARPOINT NEURO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
CLEARPOINT NEURO Aktie jetzt für 0€ handeln
14:14ClearPoint Neuro, Inc.: ClearPoint Neuro Announces Full Market Release of ClearPoint Navigation Software Version 3.0 - Delivering the First End-to-End ClearPoint Navigation Solution to the Operating Room122The platform will be showcased at the American Academy of Neurological Surgeons Annual Meeting in Boston on April 25-28, 2025. SOLANA BEACH, CALIFORNIA / ACCESS Newswire / April 24, 2025 / ClearPoint...
► Artikel lesen
01.04.Stifel raises Clearpoint Neuro stock target to $25 on growth potential1
26.02.ClearPoint Neuro, Inc. - 10-K, Annual Report-
26.02.ClearPoint Neuro, Inc.: ClearPoint Neuro Reports Fourth Quarter and Full Year 2024 Results331Achieved Record Revenue for 2024 and Growth of 31%;Reduced 2024 Operational Cash Burn by 35% SOLANA BEACH, CALIFORNIA / ACCESS Newswire / February 26, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the...
► Artikel lesen
26.02.ClearPoint Neuro, Inc. - 8-K, Current Report1
14.02.ClearPoint Neuro, Inc.: ClearPoint Neuro to Announce Fourth Quarter and Full Year 2024 Results February 26, 2025229SOLANA BEACH, CA / ACCESS Newswire / February 14, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to...
► Artikel lesen
12.02.ClearPoint Neuro, Inc.: ClearPoint Neuro Announces EU MDR Certification for the SmartFlow Cannula524SOLANA BEACH, CA / ACCESS Newswire / February 12, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to...
► Artikel lesen
28.01.CLPT Stock Gains on FDA Clearance for Navigation Software Version 3.03
27.01.ClearPoint Neuro gains FDA clearance for software2
27.01.ClearPoint Neuro, Inc.: ClearPoint Neuro Announces FDA Clearance for ClearPoint Navigation Software Version 3.01.097SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 27, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation...
► Artikel lesen
14.11.24ClearPoint Neuro, Inc.: ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain600Only Device Approved to Deliver First Disease-Modifying Treatment for AADC Deficiency in the United StatesSOLANA BEACH, CA / ACCESSWIRE / November 13, 2024 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the...
► Artikel lesen
07.11.24ClearPoint Neuro, Inc.: ClearPoint Neuro Reports Third Quarter 2024 Results470Achieved Record Revenue and Growth of 41%; Operational Cash Burn Reduced to $1.2 Million SOLANA BEACH, CA / ACCESSWIRE / November 7, 2024 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global...
► Artikel lesen
07.11.24ClearPoint Neuro, Inc. - 8-K, Current Report-
07.11.24ClearPoint Neuro, Inc. - 10-Q, Quarterly Report1
31.10.24ClearPoint Neuro, Inc.: ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2024736President and CEO Joe Burnett Interview Highlighted on Bloomberg Intelligence Vanguards of Healthcare Podcast TodaySOLANA BEACH, CA / ACCESSWIRE / October 31, 2024 / ClearPoint Neuro, Inc. (NASDAQ:CLPT)...
► Artikel lesen
15 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1